Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check8 days agoChange DetectedThe page’s revision tag changed from v3.6.2 to v3.6.3, signaling a minor platform/template update.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a small update to the page or its template without changes to the study information.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page adds new user-guidance sections and reflects a recruitment status change, including No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and standardizes the Intervention/Treatment label. It also updates the page revision to v3.6.0 and removes the older Intervention / Treatment label and Revision: v3.5.5.SummaryDifference0.5%

- Check36 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous v3.5.3. This is an administrative update to the page's revision metadata and does not modify study content or results.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page’s footer release version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a change to the ClinicalTrials.gov site version rather than the underlying study record.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.